A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer

NCT01907529 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Stage III Breast Cancer

Interventions

DRUG: docetaxel, epirubicin and cyclophosphamide
DRUG: docetaxel, epirubicin and cyclophosphamide plus endostar

Sponsor

Hebei Medical University Fourth Hospital